(157 days)
Not Found
No
The description mentions embedded software for controlling vacuum pressure and cycle speed, but there is no indication of AI or ML being used for learning, adaptation, or complex decision-making based on data. The software appears to be deterministic control logic.
No
Explanation: The device is described as an Electric Breast Pump intended to express and collect milk from lactating women. While it assists a physiological process, it does not treat or cure a disease, nor does it restore a damaged body part or function. Therefore, it is not considered a therapeutic device.
No
The device is an electric breast pump intended to express and collect milk, which is a therapeutic or assistive function, not a diagnostic one.
No
The device description explicitly states it is a "powered breast pump" that uses a "diaphragm-type vacuum pump" driven by embedded software. This indicates the device includes significant hardware components beyond just software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information about a person's health. They are used outside of the body to analyze biological samples.
- Device Function: The Electric Breast Pump Model: YM-8166 is used to collect breast milk directly from the body. It does not analyze or test the milk or any other biological sample. Its function is purely mechanical (generating suction) to facilitate the expression of milk.
- Intended Use: The intended use is to "express milk from lactating women in order to collect milk from their breasts." This is a physical process, not a diagnostic one.
The provided information clearly describes a device that interacts with the body to collect a substance, not a device that analyzes a biological sample for diagnostic purposes.
N/A
Intended Use / Indications for Use
The Electric Breast Pump Model: YM-8166 is intended to express milk from lactating women in order to collect milk from their breasts. The device is intended for a single user.
Product codes (comma separated list FDA assigned to the subject device)
HGX
Device Description
The Electric Breast Pump Model: YM-8166 is an over-the-counter, non-sterile, single-user, powered breast pump intended to be used by lactating women to express and collect milk from their breasts. The device is intended for daily use in a home environment. The device uses a diaphragm-type vacuum pump driven by software embedded in the device to generate suction required to stimulate and express breast milk. The software provides control over vacuum pressure and cycle speed.
The following patient-contacting materials are used in the subject device:
Component name: Electric Breast Pump Model: YM-8166 (Major ingredients)
Material of Component: PP & Silicone
Body Contact Category: Surface-contacting device: Intact skin
Contact Duration: Less than 24 hours
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Breast
Indicated Patient Age Range
Lactating women
Intended User / Care Setting
Home environment
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
1) Biocompatibility Testing
The biocompatibility evaluation for the patient-contacting components of the Electric Breast Pump Model: YM-8166 was conducted in accordance with the "Use of International Standard ISO 10993-1, 'Biological Evaluation of Medical Devices -Part 1: Evaluation and Testing Within a Risk Management Process, Document Issued on September 4, 2020", as follows:
- ISO 10993-5:2009. Biological evaluation of medical devices -Part 5: Tests for in vitro cytotoxicity
- ISO 10993-10:2021, Biological evaluation of medical devices -Part 10: Tests for skin sensitization
- ISO 10993-23:2021, Biological evaluation of medical devices -Part 23: Tests for skin irritation
The patient-contacting components of the subject device were shown to be non-cytotoxic, nonirritating, and non-sensitizing.
2) Electrical Safety and EMC
Electrical safety and EMC testing was performed per the following standards:
- IEC 60601-1-2 Medical electrical equipment -Part 1-2: General requirements for basic safety and essential performance -Collateral standard: electromagnetic compatibility
- ANSI AAMI ES60601-1 Medical electrical equipment Part 1: General requirements for basic safety and essential performance
- IEC 60601-1-11 Medical Electrical Equipment -Part 1: General Requirements for Basic Safety and Essential Performance -Collateral Standard: Requirements for Medical Electrical Equipment and Medical Electrical Systems Used in the Home Healthcare Environment
- IEC 62133-2 Secondary cells and batteries containing alkaline or other non-acid electrolytes -Safety requirements for portable sealed secondary cells, and for batteries made from them, for use in portable applications - Part 2: Lithium systems
3) Software Verification and Validation
Software verification and validation consistent with a basic level of concern per the FDA guidance document "Content of Premarket Submissions for Device Software Functions" dated June 14, 2023. System validation testing presented in this 510(k) demonstrated that all software requirement specifications are met, and all software hazards have been mitigated to acceptable risk levels.
4) Additional Non-Clinical Testing
Suction strength and cycle speed of subject devices were tested. All the test results complied with the design specifications of the subject device throughout the use life.
Backflow testing was conducted to ensure that no liquid will backflow into the tubing, and therefore no liquid can backflow into the pump motor. The test results showed that there was no backflow during the test.
Battery performance testing was conducted to demonstrate that the battery remains functional during its stated use-life.
Battery status indicator testing was conducted to demonstrate that the battery status indicator remains functional during its stated battery life.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 884.5160 Powered breast pump.
(a)
Identification. A powered breast pump in an electrically powered suction device used to express milk from the breast.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
January 19, 2024
Guangdong Youmeng Electrical Technology Co., Ltd. % Candice Oiu Registration Engineer Feiying Drug & Medical Consulting Technical Service Group Rm. 2401 Zhenye International Business Center, No. 3101-90. Qianhai Road Shenzhen, Guangdong 518052 China
Re: K232466
Trade/Device Name: Electric Breast Pump Model: YM-8166 Regulation Number: 21 CFR$ 884.5160 Regulation Name: Powered Breast Pump Regulatory Class: II Product Code: HGX Dated: December 5, 2023 Received: December 21, 2023
Dear Candice Qiu:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
2
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30. Design controls; 21 CFR 820.90. Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
2
Page
3
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for mhre information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Monica D. Garcia -S
Monica D. Garcia, Ph.D. Assistant Director DHT3B: Division of Reproductive, Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological HealtH
Enclosure
3
Indications for Use
510(k) Number (if known) K232466
Device Name Electric Breast Pump Model: YM-8166
Indications for Use (Describe)
The Electric Breast Pump Model: YM-8166 is intended to express milk from lactating women in order to collect milk from their breasts. The device is intended for a single user.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ------------------------------------------------- | -- |
Prescription Use (Part 21 CFR 801 Subpart D)
|X | Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
K232499 510(k) Summary
"510(k) Summary" as required by 21 CFR Part 807.92.
Date Prepared: January 17, 2023
I. Submitter
Guangdong Youmeng Electrical Technology Co., Ltd. One of Area A, level 3, Building 2, No. 17, Keyuan 3rd Road, Shunde Hi Tech Industrial Park, Xiaohuangpu Community, Ronggui Street, Shunde District, Foshan, Guangdong, China Post code: 528303 Tel.: +86 13567769890 Liu Zongjun General Manager Tel: +86 13567769890 Email: 223316378@qq.com
II. Device
Name of Device: Electric Breast Pump Model: YM-8166 Common or Usual Name: Powered breast pump Regulation Name: Powered breast pump Regulation Number: 21 CFR 884.5160 Regulatory Class: II Product Code: HGX (Powered, Breast, Pump)
III. Predicate Device
Predicate device:
| Manufacturer | Predicate Device | 510(k) Number | Clearance Date |
|---|---|---|---|
| Zhejiang Carebao Co., Ltd. | Wearable Breast Pump (YD-1193, YD-1193S, YD1195, YD-1195S, YD-1196, YD-1198, YD-1199, YD-1196S, YD- 1198S, YD-1199S) | K222782 | Jan 13, 2023 |
The predicate device has not been subject to a design-related recall.
5
IV. Device Description
The Electric Breast Pump Model: YM-8166 is an over-the-counter, non-sterile, single-user, powered breast pump intended to be used by lactating women to express and collect milk from their breasts. The device is intended for daily use in a home environment. The device uses a diaphragm-type vacuum pump driven by software embedded in the device to generate suction required to stimulate and express breast milk. The software provides control over vacuum pressure and cycle speed.
The following patient-contacting materials are used in the subject device:
| Component
| name | Material of Component | Body Contact Category | Contact Duration |
|---|---|---|---|
| Electric Breast | |||
| Pump Model: | |||
| YM-8166 | |||
| (Major | |||
| ingredients) | PP & Silicone | Surface-contacting | |
| device: Intact skin | Less than 24 hours |
Detailed device specifications can be found in the comparison chart below.
V. Indications for Use
The Electric Breast Pump Model: YM-8166 is intended to express milk from lactating women in order to collect milk from their breasts. The device is intended for a single user.
VI. Comparison of Technological Characteristics with the Predicate Device
The table below compares the intended use and technological characteristic of the subject and predicate device.
| Comparison
| Elements | Subject Device | Predicate Device | Remark |
|---|---|---|---|
| 510(k) Number | K232499 | K222782 | / |
| Trade name | Electric Breast Pump | ||
| Model: YM-8166 | Wearable Breast Pump | ||
| (YD-1193, YD-1193S, | |||
| YD1195, YD-1195S, YD- | |||
| 1196 YD-1198 YD-1199) | / | ||
| Comparison | |||
| Elements | Subject Device | Predicate Device | Remark |
| YD-1196S, YD- 1198S, YD- | |||
| 1199S) | |||
| Manufacturer | Guangdong Youmeng | ||
| Electrical Technology | |||
| Co., Ltd. | Zhejiang Carebao Co., Ltd. | / | |
| Regulation number | 21 CFR 884.5160 | 21 CFR 884.5160 | Same |
| Product code | HGX | HGX | Same |
| Device | |||
| classification | Class II | Class II | Same |
| Indication for use/ | |||
| Intended use | The Electric Breast | ||
| Pump Model: YM-8166 | |||
| is intended to express | |||
| milk from lactating | |||
| women in order to | |||
| collect milk from their | |||
| breasts. The device is | |||
| intended for a single | |||
| user. | The Wearable Breast Pump is | ||
| intended to express milk from | |||
| lactating women in order to | |||
| collect milk from their | |||
| breasts. The device is | |||
| intended for a single user. | Same | ||
| Prescription or | |||
| OTC | OTC | OTC | Same |
| Pump Options | Single, Double | Single | Different |
| Provide Non-sterile | Yes | Yes | Same |
| Re-usable | Yes | Yes | Same |
| Direct user contact | Yes | Yes | Same |
| Backflow | |||
| Protection | Yes | Yes | Same |
| Suction Modes | Stimulation Mode, | ||
| Expression Mode, | |||
| Pseudo-true Expression | |||
| Mode, Array Mode, | |||
| and Single/double | Stimulation Mode and | ||
| Expression Mode | |||
| Mixed Mode | Different | ||
| Comparison | |||
| Elements | Subject Device | Predicate Device | Remark |
| Pumping Mode | |||
| Suction levels | 16 | 9 | Different |
| Adjustable suction | |||
| levels | Yes | Yes | Same |
| Vacuum range: | |||
| Stimulation mode | 60-165±20 (mmHg) | YD-1193,YD -1193S, YD- | |
| 1195,YD-1195S: 36 mmHg | |||
| to 241 mmHg | |||
| YD-1196,YD-1198, YD- | |||
| 1199, YD-1196S, YD- | |||
| 1198S, YD-1199S: 37 mmHg | |||
| to 242 mmHg | Similar | ||
| Vacuum range: | |||
| Expression mode | 85-280±20 (mmHg) | YD-1193,YD -1193S, YD- | |
| 1195,YD-1195S: 69 mmHg | |||
| to 282 mmHg | |||
| YD-1196,YD-1198, YD- | |||
| 1199, YD-1196S, YD- | |||
| 1198S, YD-1199S: 71 mmHg | |||
| to 282 mmHg | Similar | ||
| Cycle Speed: | |||
| Stimulation | Single Suction: 66 to | ||
| 138±5 cycles/minute | |||
| Double suction: 64 to | |||
| 180±5 cycles/minute | 37.5 to 150 cycles/minute | Different | |
| Cycle Speed: | |||
| Expression | Single Suction: 32 to | ||
| 112±5 cycles/minute | |||
| Double suction:28 to | |||
| 132±5 cycles/minute | YD-1193,YD -1193S, YD- | ||
| 1195,YD-1195S: 23 to 72 | |||
| cycles/minute | |||
| YD-1196, YD-1198, YD- | |||
| 1199, YD-1196S, YD- | |||
| 1198S, YD-1199S: 24 to 69 | |||
| cycles/minute | Different | ||
| Controls | Power button; | ||
| Mode | |||
| adjustment | |||
| button; | |||
| Vacuum level increase/ | On/Off button; Mode | ||
| selection Increase/decrease | |||
| vacuum button; | Similar | ||
| Comparison | |||
| Elements | Subject Device | Predicate Device | Remark |
| decrease button; | |||
| Night light button | |||
| (optional) ; | |||
| Single/ double pumping | |||
| change button | |||
| Indicator | Yes. General display | Yes. LED | Same |
| Power Supply | USB connector (Only | ||
| for charging) by DC 5 | |||
| V, 2 A | Li-Ion Battery (internally | ||
| powered by 3.7Vdc lithium | |||
| battery or externally powered | |||
| by 5Vdc USB.) | Same | ||
| Materials | Milk collection bottle: | ||
| PP and PPSU | |||
| (Optional) | |||
| Breast shield: Silicone | |||
| rubber | |||
| Pump unit: ABS and PC | Milk Container: | ||
| Polypropylene | |||
| Flange: Silicone Pump Outer | |||
| Housing: Acrylonitrile | |||
| Butadiene Styrene (ABS) | |||
| plastic | Same | ||
| Software/ | |||
| Firmware/ | |||
| Microprocessor | |||
| Control? | Yes | Yes | Same |
| Electrical safety | IEC 60601-1 | ||
| IEC 60601-1-2 | |||
| IEC 60601-1-11 | |||
| IEC 62133-2 | AAMI ANSI ES60601-1:2005/(R)2012 and A1:2012 | ||
| IEC 60601-1-2 | |||
| IEC 60601-1-11 | |||
| IEC 62133-2 | Same | ||
| Biocompatibility | ISO 10993-5 | ||
| ISO 10993-10 | |||
| ISO 10993-23 | ISO 10993-5 | ||
| ISO 10993-10 | Same |
6
7
8
The Electric Breast Pump Model: YM-8166 has the same intended use, mode of action and similar operational characteristics as the predicate device. The subject device differs from the predicate device in suction modes, strength, and levels, cycle speed, and a double pumping option. The different technological characteristics between the subject device and the predicate device do not raise different questions of safety and effectiveness.
9
VII.Summary of Non-Clinical Performance Testing
1) Biocompatibility Testing
The biocompatibility evaluation for the patient-contacting components of the Electric Breast Pump Model: YM-8166 was conducted in accordance with the "Use of International Standard ISO 10993-1, 'Biological Evaluation of Medical Devices -Part 1: Evaluation and Testing Within a Risk Management Process, Document Issued on September 4, 2020", as follows:
-
ISO 10993-5:2009. Biological evaluation of medical devices -Part 5: Tests for in vitro cytotoxicity
-
ISO 10993-10:2021, Biological evaluation of medical devices -Part 10: Tests for skin sensitization
-
ISO 10993-23:2021, Biological evaluation of medical devices -Part 23: Tests for skin irritation
The patient-contacting components of the subject device were shown to be non-cytotoxic, nonirritating, and non-sensitizing.
2) Electrical Safety and EMC
Electrical safety and EMC testing was performed per the following standards:
-
IEC 60601-1-2 Medical electrical equipment -Part 1-2: General requirements for basic safety and essential performance -Collateral standard: electromagnetic compatibility
-
ANSI AAMI ES60601-1 Medical electrical equipment Part 1: General requirements for basic safety and essential performance
-
IEC 60601-1-11 Medical Electrical Equipment -Part 1: General Requirements for Basic Safety and Essential Performance -Collateral Standard: Requirements for Medical Electrical Equipment and Medical Electrical Systems Used in the Home Healthcare Environment
-
IEC 62133-2 Secondary cells and batteries containing alkaline or other non-acid electrolytes -Safety requirements for portable sealed secondary cells, and for batteries made from them, for use in portable applications - Part 2: Lithium systems
3) Software Verification and Validation
Software verification and validation consistent with a basic level of concern per the FDA guidance document "Content of Premarket Submissions for Device Software Functions" dated June 14, 2023. System validation testing presented in this 510(k) demonstrated that all software requirement specifications are met, and all software hazards have been mitigated to acceptable risk levels.
10
4) Additional Non-Clinical Testing
Suction strength and cycle speed of subject devices were tested. All the test results complied with the design specifications of the subject device throughout the use life.
Backflow testing was conducted to ensure that no liquid will backflow into the tubing, and therefore no liquid can backflow into the pump motor. The test results showed that there was no backflow during the test.
Battery performance testing was conducted to demonstrate that the battery remains functional during its stated use-life.
Battery status indicator testing was conducted to demonstrate that the battery status indicator remains functional during its stated battery life.
VIII. Conclusions
The results of the performance testing described above demonstrate that the Electric Breast Pump Model: YM-8166 is as safe and effective as the predicate device and supports a determination of substantial equivalence.